Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.

CEO

Lars Fruergaard Jørgensen

CEOLars Fruergaard Jørgensen

Employees

76,302

Employees76,302

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1931

Founded1931

Employees

76,302

Employees76,302

NVO Key Statistics

Market cap

315.10B

Market cap315.10B

Price-Earnings ratio

20.52

Price-Earnings ratio20.52

Dividend yield

1.70%

Dividend yield1.70%

Average volume

8.40M

Average volume8.40M

High today

$70.60

High today$70.60

Low today

$69.03

Low today$69.03

Open price

$69.45

Open price$69.45

Volume

2.39M

Volume2.39M

52 Week high

$143.69

52 Week high$143.69

52 Week low

$57.00

52 Week low$57.00

NVO News

Benzinga 24h

Hims & Hers Navigates Novo Nordisk Breakup And Compounding Lawsuits

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 1...

TipRanks 5d

Novo Nordisk’s Diabetes Study: Promising Results for Cagrilintide and Semaglutide Combo

Novo Nordisk ((DE:NOVA)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% of...

TipRanks 5d

Novo Nordisk’s CagriSema Study: A Potential Game-Changer in Obesity Treatment

Novo Nordisk ((DE:NOVA)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% of...

Analyst ratings

63%

of 32 ratings

Buy

62.5%

Hold

28.1%

Sell

9.4%